Atlas Trials

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Clinical trial NCT03596073 · TERMINATED

Trial details

NCT number
NCT03596073
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2018-11-07
Primary completion
2020-08-31
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.